High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibrillation

European Heart Journal: Acute Cardiovascular Care

Volumn 5, Issue 6, 2016, Pages 419-427

  Sörensen, Nils A ^a   Shah, Anoop S V ^b   Ojeda, Francisco M ^a   Peitsmeyer, Philipp ^a   Zeller, Tanja ^a,c   Keller, Till ^c,d   Johannsen, Silke S ^a,c   Lackner, Karl J ^e   Griffiths, Megan ^b   Münzel, Thomas ^c,e   Mills, Nicholas L ^b   Blankenberg, Stefan ^a,c   Schnabel, Renate B ^a,c  

^a University Heart Center   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Atrial fibrillation; Diagnosis; High sensitivity troponin I; Non ST segment elevation myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; COPEPTIN; CREATINE KINASE; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE; GROWTH DIFFERENTIATION FACTOR 15; MYELOPEROXIDASE; MYOGLOBIN; PLACENTAL GROWTH FACTOR; TROPONIN I; FABP3 PROTEIN, HUMAN; GLYCOPEPTIDE; PHARMACOLOGICAL BIOMARKER; TROPONIN T;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SMOKING; UNSTABLE ANGINA PECTORIS; ANGINA PECTORIS; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; COMPLICATION; EARLY DIAGNOSIS; MULTICENTER STUDY; NON-ST ELEVATED MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; ANGINA PECTORIS; AREA UNDER CURVE; ATRIAL FIBRILLATION; BIOMARKERS, PHARMACOLOGICAL; EARLY DIAGNOSIS; FATTY ACID-BINDING PROTEINS; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; NON-ST ELEVATED MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 85016062745     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872615611108     Document Type: Article

References (33)

1. Atzema CL, Austin PC, Miller E, et al. A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. Ann Emerg Med 2013; 62: 570-577.
2. Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-1045.
3. Poci D, Hartford M, Karlsson T, et al. Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome. Am J Cardiol 2012; 110: 217-221.
4. Chamberlain AM, Bielinski SJ, Weston SA, et al. Atrial fibrillation in myocardial infarction patients: Impact on health care utilization. Am Heart J 2013; 166: 753-759.
5. Schnabel RB, Rienstra M, Sullivan LM, et al. Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail 2013; 15: 843-849.
6. Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014; 174: 107-114.
7. Atzema CL, Lam K, Young C, et al. Patients with atrial fibrillation and an alternative primary diagnosis in the emergency department: a description of their characteristics and outcomes. Acad Emerg Med 2013; 20: 193-199.
8. Bukkapatnam RN, Robinson M, Turnipseed S, et al. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol 2010; 106: 374-377.
9. Parwani AS, Boldt LH, Huemer M, et al. Atrial fibrillationinduced cardiac troponin I release. Int J Cardiol 2013; 168: 2734-2737.
10. Morello A, Lloyd-Jones DM, Chae CU, et al. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007; 153: 90-97.
11. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-867.
12. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011; 306: 2684-2693.
13. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-1660.
14. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
15. Shah ASV, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 2015; 350: 7873.
16. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-2567.
17. Mills NL, Churchhouse AMD, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011; 305: 1210-1216.
18. Mills NL, Lee KK, McAllister DA, et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ 2012; 344: e1533.
19. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941-1951.
20. Zeller T, Ojeda F, Brunner FJ, et al. High-sensitivity cardiac troponin I in the general population-defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med 2015; 53(5): 699-706.
21. Tzikas S, Keller T, Ojeda FM, et al. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain. Heart 2013; 99(6): 388-395.
22. DeLong ER, DeLong DM and Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
23. Almendro-Delia M, Valle-Caballero MJ, Garcia-Rubira JC, et al. Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry. Eur Heart J Acute Cardiovasc Care 2014; 3: 141-148.
24. Otaki Y, Arimoto T, Takahashi H, et al. Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation. Intern Med 2014; 53: 661-668.
25. Hijazi Z, Siegbahn A, Andersson U, et al. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation 2014; 129: 625-634.
26. Gupta K, Pillarisetti J, Biria M, et al. Clinical utility and prognostic significance of measuring troponin I levels in patients presenting to the emergency room with atrial fibrillation. Clin Cardiol 2014; 37: 343-349.
27. Mockel M, Searle J, Hamm C, et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 2015; 36: 369-376.
28. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009; 54: 60-68.
29. Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010; 55: 2096-2106.
30. Balmelli C, Meune C, Twerenbold R, et al. Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. Am Heart J 2013; 166: 30-37.
31. Reiter M, Twerenbold R, Reichlin T, et al. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. Heart 2013; 99: 708-714.
32. McMahon CG, Lamont JV, Curtin E, et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med 2012; 30: 267-274.
33. Liebetrau C, Nef HM, Dorr O, et al. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction. Heart 2014; 100: 652-657.